Fractional CO₂ Laser Therapy for Vulvo-Vaginal Health
Hormonal changes linked to menopause, cancer treatment or surgery can impact intimate comfort, confidence and quality of life.
MonaLisa Touch is a clinically researched fractional CO₂ laser treatment designed to support vaginal tissue health by stimulating collagen production and tissue renewal. Non-hormonal and minimally invasive, it delivers quick, in-clinic treatments with minimal downtime.
MonaLisa Touch is trusted by gynaecologists and women’s health specialists worldwide and supported by over 100 peer-reviewed studies.
Dr Paula Briggs, Consultant in Sexual & Reproductive Health at Liverpool Women’s Hospital, describes patient feedback as “extremely positive”, particularly for women with a history of hormone-dependent cancer.
Professor Mickey Karram, Director of the Fellowship Program in Female Pelvic Medicine and Reconstructive Surgery at The Christ Hospital, calls MonaLisa Touch “a game changer”, with patients reporting improved moisture, reduced pain and greater comfort after treatment.
Dr Stefano Salvatore, Associate Professor in Obstetrics and Gynaecology at Vita-Salute San Raffaele University, states that histological studies have shown MonaLisa Touch can help restore vaginal mucosa to a premenopausal condition.
MonaLisa Touch uses fractional CO₂ laser technology to stimulate biological regeneration within the vaginal mucosa. Using DEKA’s patented D-Pulse technology, controlled laser energy creates micro-stimulation within the tissue to encourage collagen production, improve hydration and support healthy tissue remodelling.
This regenerative response helps restore elasticity, thickness and overall vaginal tissue health while protecting surrounding areas through precise, controlled energy delivery.
Treatments are quick, minimally invasive and typically require little to no downtime, making MonaLisa Touch an accessible option for women seeking non-hormonal support for intimate wellbeing.
MonaLisa Touch is a clinically supported solution for vulvo-vaginal health, helping clinics address a growing and often underserved area of care. With increasing demand for effective, non-hormonal treatment options, it enables practitioners to offer a high-value treatment that supports both client satisfaction and long-term engagement through course-based treatments and maintenance sessions.
Backed by over 100 peer-reviewed studies, MonaLisa Touch gives clinicians confidence in its safety and effectiveness while offering efficient treatment delivery with no per-treatment consumables — supporting strong commercial potential for clinics.
MonaLisa Touch is performed with the Tetra Pro, delivering controlled fractional CO₂ energy to gently stimulate tissue regeneration and restore vaginal health. Designed with both practitioner control and patient comfort in mind, it enables consistent, efficient treatments supported by strong clinical evidence.
MonaLisa Touch is a fractional CO₂ laser treatment designed to support vulvo-vaginal health by stimulating tissue regeneration within the vaginal mucosa.
It is commonly used to support women experiencing genitourinary symptoms associated with menopause, including vaginal dryness, discomfort, irritation and recurrent infections.
No. MonaLisa Touch is a non-hormonal treatment option, making it suitable for clients who cannot or prefer not to use hormone therapies.
A treatment session typically takes around five minutes and is performed as an in-clinic procedure.
Protocols commonly involve a course of three treatments spaced over several weeks, although this can vary depending on clinical assessment.
MonaLisa Touch may be suitable for women experiencing vulvo-vaginal symptoms linked to hormonal change, including those associated with menopause or certain cancer treatments. Suitability should always be assessed by a qualified clinician.
Results can vary between clients, but improvements are often seen following an initial course of treatments. Maintenance sessions may be recommended to help sustain results over time.
Yes. By stimulating collagen production and tissue remodelling, the treatment can help improve hydration and mucosal health, which reduces the symptoms of vaginal dryness.
No. MonaLisa Touch is a non-surgical treatment that uses fractional CO₂ laser energy to stimulate natural tissue regeneration.
Some clients report improvements after the first treatment, although optimal outcomes are typically achieved following a full course of sessions.
Yes. MonaLisa Touch is used by clinicians worldwide and supported by a growing body of peer-reviewed clinical research.
MonaLisa Touch uses fractional CO₂ laser energy with DEKA’s patented D-Pulse emission to deliver controlled thermal stimulation to the vaginal mucosa.
Lynton provides comprehensive hands-on training to help clinicians feel confident delivering MonaLisa Touch treatments safely, effectively and professionally.
Yes. Our team supports clinics with treatment integration, patient communication guidance and practical advice to help introduce MonaLisa Touch successfully into existing services.
Absolutely. Clinics gain access to professionally designed marketing materials, digital assets and patient education content to help promote treatments and increase awareness.
MonaLisa Touch supports long-term patient engagement through course-based treatments and maintenance sessions, helping clinics build recurring revenue opportunities within an expanding treatment category.
Yes. Alongside clinical training, clinics benefit from ongoing business and commercial support designed to help maximise treatment uptake and long-term device success.
